Rmb Capital Management, LLC Crispr Therapeutics Ag Transaction History

Rmb Capital Management, LLC

$4.3 Billion
Q3 2024

A detailed history of Rmb Capital Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Rmb Capital Management, LLC holds 46,715 shares of CRSP stock, worth $1.91 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

46,715

Previous 39,118 19.42%

Holding current value

$1.91 Million

Previous $2.11 Million 3.93%

% of portfolio

0.05%

Previous 0.05%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$44.62 - $62.75 $338,978 - $476,711	7,597 Added 19.42%	46,715 $2.2 Million
Q2 2024 Aug 13, 2024	BUY	$51.17 - $68.18 $245,820 - $327,536	4,804 Added 14.0%	39,118 $2.11 Million
Q1 2024 May 14, 2024	BUY	$60.67 - $89.12 $170,118 - $249,892	2,804 Added 8.9%	34,314 $2.34 Million
Q4 2023 Feb 14, 2024	BUY	$38.62 - $72.18 $3,553 - $6,640	92 Added 0.29%	31,510 $1.97 Million
Q3 2023 Nov 13, 2023	SELL	$45.39 - $59.0 $6,899 - $8,968	-152 Reduced 0.48%	31,418 $1.43 Million
Q1 2023 May 11, 2023	BUY	$41.0 - $56.12 $198,235 - $271,340	4,835 Added 18.08%	31,570 $1.43 Million
Q4 2022 Feb 14, 2023	SELL	$39.19 - $65.67 $372,148 - $623,602	-9,496 Reduced 26.21%	26,735 $1.09 Million
Q2 2022 Aug 01, 2022	SELL	$43.23 - $73.83 $164,057 - $280,184	-3,795 Reduced 9.48%	36,231 $2.2 Million
Q1 2022 May 06, 2022	SELL	$53.19 - $79.24 $1.78 Million - $2.65 Million	-33,397 Closed	0 $0
Q4 2021 Jan 26, 2022	BUY	$70.09 - $111.29 $781,363 - $1.24 Million	11,148 Added 50.11%	33,397 $2.53 Million
Q3 2021 Oct 20, 2021	BUY	$110.2 - $156.64 $661 - $939	6 Added 0.03%	22,249 $2.49 Million
Q2 2021 Aug 13, 2021	BUY	$100.84 - $161.89 $1.11 Million - $1.78 Million	10,981 Added 97.5%	22,243 $3.6 Million
Q1 2021 May 12, 2021	BUY	$110.72 - $210.04 $1.25 Million - $2.37 Million	11,262 New	11,262 $1.37 Million
Q4 2020 Feb 11, 2021	SELL	$79.67 - $173.23 $231,043 - $502,366	-2,900 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$38.5 - $76.05 $111,650 - $220,545	2,900 New	2,900 $213,000

Others Institutions Holding CRSP

# of Institutions

490

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.19B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rmb Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rmb Capital Management, LLC with notifications on news.

Account

Rmb Capital Management, LLC Crispr Therapeutics Ag Transaction History